Anti-ICAM-1 monoclonal antibody YN1/1.7.4

Drug Profile

Anti-ICAM-1 monoclonal antibody YN1/1.7.4

Alternative Names: YN1/1.7; YNI/1.7

Latest Information Update: 01 Sep 1998

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Developer Isis Pharmaceuticals; Nonindustrial source
  • Class Monoclonal antibodies
  • Mechanism of Action Intercellular adhesion molecule 1 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Transplant rejection

Most Recent Events

  • 01 Sep 1998 No-Development-Reported for Transplant rejection in Japan (Unknown route)
  • 01 Sep 1998 No-Development-Reported for Transplant rejection in USA (Unknown route)
  • 04 Nov 1996 A study has been added to the Transplant Rejection pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top